Recon: Nvidia, Lilly partner on $1B joint research AI lab; FDA rejects Atara’s blood cancer treatment
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- ChatGPT and Claude get into the business of health advice. Should you trust them? (STAT)
- Investor behind Moderna says U.S. policy is ‘taking a sledgehammer to our miracle machine’ (STAT)
- Novo CEO Sees Obesity Pill Opening Doors to a New Market in US (Bloomberg)
- Trump says he may veto extension of Obamacare subsidies (Reuters)
- FDA shares ‘more flexible approach’ to overseeing cell and gene therapy manufacturing (Endpoints)
- FDA lifts partial hold on Merck, Daiichi's trial for B7-H3 antibody-drug conjugate (Endpoints)
- French Government Says No Contact With Eli Lilly on Abivax (Bloomberg)
- Chinese Startup Making Tech to Rival Neuralink Said to File for Hong Kong IPO (Bloomberg)
- AbbVie jumps into PD-1xVEGF bispecifics race, paying $650M upfront to China's RemeGen (Endpoints)
- Global Pharma Guidance Tracker – December 2025 (Pink Sheet)
- EU Pharmacopoeia Takes Another Step Toward Animal-Free Testing With Recombinant Factor C (Pink Sheet)
- US FDA declines to approve Atara's therapy for rare blood cancer (Reuters)
- Lilly Now Sees Obesity Pill Approval as Early as Second Quarter (Bloomberg)
- Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly (Bloomberg)
- Lilly will have supply of new weight loss pill for many countries, exec says (Reuters)
- Moderna Sees Sales Boost as Covid Shots Beat Expectations (Bloomberg)
- JPMorgan Healthcare Conference Won’t Limit Deals to Just Biopharma (Bloomberg)
- Arkin Capital raises $100M to back a dozen early-stage biotechs (Endpoints)
- Edwards calls off JenaValve buyout after court halts deal (MedTech Dive)
- Illumina names former NIH genomics director as chief medical officer (MedTech Dive)
- Haemonetics to acquire Vivasure Medical (MedTech Dive)
- Medtech 2026: Geopolitical Uncertainty Shapes Industry’s Future (MedTech Insight)
- Medtech 2026: Last Year Brought Technical Advances Alongside Regulatory Challenges (MedTech Insight)
- A new entry in the dietary guidelines: advice on maintaining healthy testosterone levels (STAT)
- Kennedy shakes up dietary guidelines: Winners and losers (The Hill)
- Judge orders HHS to restore funding for children’s health programs as lawsuit continues (STAT)
- The NIH has lost its scientific integrity. So we left (STAT)
- Government approves $60 billion of enhanced Medicaid funding for hospitals, other providers (STAT)
- UnitedHealth Used ‘Aggressive’ Medicare Strategy, Senate Report Says (Bloomberg)
- Walmart makes tepid return to healthcare (Endpoints)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
